Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
RAISE
The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
2 other identifiers
interventional
48
1 country
1
Brief Summary
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP(E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYA with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2025
CompletedFirst Posted
Study publicly available on registry
August 24, 2025
CompletedStudy Start
First participant enrolled
October 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedDecember 5, 2025
August 1, 2025
6 months
August 18, 2025
November 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll
Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Intervention Feasibility: Proportion of Participants Completing the Program
Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Intervention Acceptability
Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Study Arms (1)
Psychosocial Intervention for Parental Caregivers of AYA with Cancer
EXPERIMENTALThe study team aims to evaluate the feasibility and acceptability of the adapted psychosocial intervention to 1) improve psychological resiliency to stress and 2) reduce symptoms of depression, anxiety, and post-traumatic stress among parental caregivers, through a single-arm open pilot trial of 32 parents.
Interventions
A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.
Eligibility Criteria
You may qualify if:
- Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer
- Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer
- Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer
- English-speaking
- Aged over 18 years
You may not qualify if:
- Having a co-parent or other household member participating in the same study
- Active symptoms of psychosis or suicidal ideation that would preclude safe participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American Cancer Society, Inc.collaborator
- Zeba Ahmad, Ph.D.lead
Study Sites (1)
Mass General Brigham Cancer Institute at Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Staff Psychologist
Study Record Dates
First Submitted
August 18, 2025
First Posted
August 24, 2025
Study Start
October 22, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
December 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share